Specimen Analysis for Understanding Pulmonary Fibrosis
This study aims to procure and analyze blood and tissue samples to understand pulmonary fibrosis in individuals with the condition, their family members, and healthy volunteers.
Data Collection
Collected at a single point in time - Cross-sectionalAlbinism+27
+ Amino Acid Metabolism, Inborn Errors
+ Blood Coagulation Disorders
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: June 9, 2004
Actual date on which the first participant was enrolled.This study aims to explore the underlying causes of pulmonary fibrosis, a lung condition with an unknown origin. Researchers are focusing on analyzing various samples from individuals diagnosed with pulmonary fibrosis, their relatives who may have hereditary links to the disease, and healthy volunteers. By examining blood, genetic material, and lung tissue obtained through procedures like bronchoscopy and biopsies, the study seeks to uncover crucial insights into how this disease develops and progresses. The findings could potentially lead to better understanding and treatment options for those affected by pulmonary fibrosis. Participants in this study will provide samples such as blood and tissue, which may be collected using different medical procedures like bronchoscopy—a procedure where a doctor looks inside the lungs with a special instrument—or through biopsies, which involve taking small samples of tissue. Some samples might also be collected after lung transplants or during post-mortem examinations. The main goal is to analyze these samples to identify patterns or abnormalities that could explain the disease. While the study involves invasive procedures, especially for those with the disease or their relatives, it holds the promise of contributing significantly to medical knowledge, potentially leading to improved diagnostics and therapies.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.315 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 115 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location